丹参
小RNA
MYB公司
生物
计算生物学
RNA干扰
药用植物
植物代谢
人参
生物技术
基因
核糖核酸
转录因子
遗传学
医学
植物
替代医学
中医药
病理
作者
Caili Li,Meizhen Wang,Xiaoxiao Qiu,Hong Zhou,Shanfa Lu
出处
期刊:Current Pharmaceutical Biotechnology
[Bentham Science]
日期:2020-05-29
卷期号:22 (3): 341-359
被引量:17
标识
DOI:10.2174/1389201021666200529101942
摘要
Background: Noncoding RNAs (ncRNAs), such as microRNAs (miRNAs), small interfering RNAs (siRNAs) and long noncoding RNAs (lncRNAs), play significant regulatory roles in plant development and secondary metabolism and are involved in plant response to biotic and abiotic stresses. They have been intensively studied in model systems and crops for approximately two decades and massive amount of information have been obtained. However, for medicinal plants, ncRNAs, particularly their regulatory roles in bioactive compound biosynthesis, are just emerging as a hot research field. Objective: This review aims to summarize current knowledge on herbal ncRNAs and their regulatory roles in bioactive compound production. Results: So far, scientists have identified thousands of miRNA candidates from over 50 medicinal plant species and 11794 lncRNAs from Salvia miltiorrhiza, Panax ginseng, and Digitalis purpurea. Among them, more than 30 miRNAs and five lncRNAs have been predicted to regulate bioactive compound production. Conclusion: The regulation may achieve through various regulatory modules and pathways, such as the miR397-LAC module, the miR12112-PPO module, the miR156-SPL module, the miR828-MYB module, the miR858-MYB module, and other siRNA and lncRNA regulatory pathways. Further functional analysis of herbal ncRNAs will provide useful information for quality and quantity improvement of medicinal plants.
科研通智能强力驱动
Strongly Powered by AbleSci AI